mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers.
about
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas.Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients.A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells.Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.High Expression of Three-Gene Signature Improves Prediction of Relapse-Free Survival in Estrogen Receptor-Positive and Node-Positive Breast Tumors.Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer.Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells.Kallistatin suppresses cancer development by multi-factorial actions.cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells.Differential overexpression of SERPINA3 in human prion diseases.
P2860
Q30978083-6DECFCFB-71DE-4183-AB25-5425B882A622Q33587519-17579732-6EDE-4E9D-93E5-57694D63D452Q33596910-F6C554AB-8870-4650-8D67-555D456E197DQ34029272-0144F40F-01C9-4746-83B4-0CA863E61E8BQ34049143-BE6D9573-E329-4CCE-BBCF-1407633701B7Q34278253-A243E424-67DF-4BD4-BC8B-DEDA11270048Q35234377-4E27BF67-1032-4D99-870C-67B62CDD859FQ35242102-2FDF1BFB-E25D-452B-AFA0-76468CA225B7Q36338015-2420FE13-4323-4E98-9845-AC1B3B4449BEQ37665209-10CF26FA-653B-4FDE-8D7B-AAF99A6BA189Q37745812-3DDBECF4-2932-4FD5-A16E-E5D5D5AD7555Q39252905-743EA7E5-AA4E-4D55-9273-A180AE44FE7EQ39885271-D7320890-11B7-4E89-BD19-1684237F16C5Q43812271-02B893C2-3B4E-4B13-8F19-486B51F13782
P2860
mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
mRNA expression level of estro ...... with invasive breast cancers.
@en
mRNA expression level of estro ...... with invasive breast cancers.
@nl
type
label
mRNA expression level of estro ...... with invasive breast cancers.
@en
mRNA expression level of estro ...... with invasive breast cancers.
@nl
prefLabel
mRNA expression level of estro ...... with invasive breast cancers.
@en
mRNA expression level of estro ...... with invasive breast cancers.
@nl
P2093
P2860
P1433
P1476
mRNA expression level of estro ...... with invasive breast cancers.
@en
P2093
Jun Yamamura
Kikuya Kato
Kyoko Iwao
Morito Monden
Shinzaburo Noguchi
Tetsuya Taguchi
Yasuhiro Tamaki
Yasuo Miyoshi
P2860
P304
P356
10.1111/J.1349-7006.2004.TB02198.X
P577
2004-11-01T00:00:00Z